patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetram
ethylenephosphate // Rev. Med. Chil. — 1998. — V. 126(8). — P. 963 971.
Lyss A.P., Virgil L.J.R.
Chemotherapy of advanced breast cancer. A general survey
// Cancer. — 1978. — V. 53. — P. 778 782.
Maas H., Jonat W.
In: Systemic control of breast cancer // Ed. B.S. Stoll
Heinemann — London: Medical. — 1987. — P. 188 203.
Macklis R.M., Cornelli H., Lasher J.
Brief courses of palliative radiotherapy for
metastatic bone pain: a pilot cost minimization comparison with narcotic analgesics //
Am. J. Clin. Oncol. — 1998. — V. 21(6). — P. 617 622.
Madsen E.L.
Painful bone metastasis: efficacy of radiotherapy assessed by the
patients: a randomised trial comparing 4 Gy * 6 versus 10 Gy * 2 // Int. J. Radiat. Oncol.
Biol. Phys. — 1983. — V. 9. — P. 1775 1779.
Malone R.M., Beye R., Walker J.
Management of pain in the terminally ill by
adminictration of epidural narcotics // Cancer. — 1985. — V.55(N2). — P. 438 440.
Mannes P., Derriks, Moens R., Laurent C., Da Iqd J.M.
Multidisciplinary curative
treatment for disseminated carcinona of the breast // Cancer Treat. Rep. — 1976(1). —
60. — P. 85 90.
Mansi J.L., Berger U, Easton D.
è ñîàâò. Micrometastases in bone marrow in
patients with primary breast cancer: evaluation as an early predictor of bone metastases //
Br. Med. J. — 1987. — V. 295. — P. 1093 1096.
Marchei P., Santini D., Bianco V., Chiodini S., Reale M.G., Simeoni F., Marchei
G.G., Vecchione A
. Serum ostase in the follow up of breast cancer patients // Anticancer
Res. — 1995 V.15(5B). — P. 2217 2222.
Martinetti A., Bajetta E., Seregni E.
Serum markers of bone metastases in post
menopausal breast cancer patients treated with formestane // Tumour Biol. — 1997. —
V.18(4). — P. 197 205.
Martoni A., Guaraldi M., Camera P.,
è ñîàâò. Controlled clinical study on the use of
dichloromethylene disphosphonate in patients with breast carcinoma metastasizing to the
skeleton // Oncology. — 1991. — V. 48. — P. 97 110.
Marty M., Gershanovich M., Campos B.,
è ñîàâò. Letrozole, a new potent, selective
aromatase inhibitor (AI) superior to aminoglutethimide (AG) in postmenopausal women
with advanced breast cancer (ABC) previously treated with anti estrogens (abstract) //
Proc. Annu. Meet. Am. Soc. Clin. Oncol. — 1997. — V. 16. — P. 544a. (Abstract).
Massida B., Jonta M.T., Foddi M.R.
Use fulness of pyridinum crosslinls and CA 15
3 as markers in metastatic bone breast carcinoma // Anticancer Res. — 1996. —V. 16 (4B). —
P. 2221 2223.
Matsubayashi T., Koga H., Nishiyama Y., Tominaga S., Sourada T.
The reparative
process of metastatic bone lesions after radiotherapy // Jpn. J. Clin. Oncol. — 1981. —
V. 11. — P. 249 253.
Mattson W., Von Eyben F., Hallsten L., Bjelkenegren G.
A phase II study of combined
5 fluorourcil and mitomycin C in advanced breast cancer // Cancer. — 1982. — V. 49. —
P. 217 220.
Maxfield J.J.R., Maxfield J.G.S., Maxfield W.S.
The use of radioactive phosphorous
and testosterone on metastatic bone lesions from breast and prostate // Sth. Med. J. —
1958. — V. 35. — P. 320.
Maurer F., Ambacher T., Volkmann R., Weller S.
Pathologic fractures: diagnostic and
therapeutic considerations and results of treatment // Langenbecks Arch .Chir. — 1995. —
V. 380(4). — P. 207 217.
237
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
